Clinical trial testing new technique to treat life-threateni
Loyola Medicine is the only center in the Midwest enrolling patients in a landmark clinical trial of a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia.

The trial is intended for patients who do not respond to either medications or a standard heart procedure called catheter ablation.